Remove BioTech Remove Development Remove Strategy
article thumbnail

The Financialization of Disruptive Technology

The Agile Manager

It's fashionable to champion an investment-oriented model for software development, particularly around exploratory opportunities. What if this is not a viable strategy? A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. Better figure it out.